<DOC>
	<DOC>NCT01875744</DOC>
	<brief_summary>Background: Aim: Clinical evaluation of the effectiveness of two different polyethylene glycol doses for the maintenance treatment of functional constipation in children. Study design: Randomized, open-label trial. Randomized, double-blind, placebo controlled trial.</brief_summary>
	<brief_title>Polyethylene Glycol for Childhood Constipation</brief_title>
	<detailed_description>Children will be randomly assigned into 2 groups receiving polyethylene glycol 4000 (Forlax) with an initial dose of either 0.3g/kg, or 0.7 g / kg. In case of ineffectiveness the dose of medication will be increased every two weeks with 0.2 g/kg. The indication for the increase in dose will be less than 3 bowel movements per week. For children with diarrhea defined as more than 3 loose stools for minimum 2 days or/and severe abdominal pain the macrogol dose of will be reduced every two weeks by 0.2 g/kg. The intervention will last 6 weeks.</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>age 1 18 age functional constipation according to the Rome III Criteria consent of parents or guardians of the child to participate and study organic cause constipation (including surgeries within the lower GI tract)</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>constipation</keyword>
	<keyword>children</keyword>
	<keyword>polyethylene glycol</keyword>
</DOC>